Brii Biosciences Limited Financial Flexibility Index
Brii Biosciences Limited financial flexibility index. Brii Biosciences Limited (7SS) has a Financial Flexibility Index of -5.85x as of December 2025. Free cash flow of €-211.82 Million (operating CF €-338.81 Million minus capex €126.99 Million) represents -6% of total liabilities (€36.20 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Brii Biosciences Limited (2020–2025)
Financial flexibility index of Brii Biosciences Limited from 2020 to 2025. Historical Financial Flexibility Index trend for Brii Biosciences Limited across 6 annual periods. Explore 7SS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Brii Biosciences Limited Financial Flexibility Index by Year (2020–2025)
Brii Biosciences Limited financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Brii Biosciences Limited. For the full cash flow conversion analysis, see 7SS cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.85x | €-211.82 Million | €-338.81 Million | €36.20 Million | ▼ -59.1% |
| 2024 | -3.68x | €-369.66 Million | €-372.89 Million | €100.55 Million | ▲ +15.0% |
| 2023 | -4.33x | €-544.41 Million | €-594.01 Million | €125.87 Million | ▼ -183.9% |
| 2022 | -1.52x | €-356.99 Million | €-496.28 Million | €234.35 Million | ▲ +47.9% |
| 2021 | -2.92x | €-878.43 Million | €-879.46 Million | €300.44 Million | ▼ -2080.4% |
| 2020 | -0.13x | €-403.72 Million | €-403.72 Million | €3.01 Billion | — |